ホーム › クローン病 › ペンシルベニア › Philadelphia
Philadelphia、PAにおけるクローン病の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、クローン病に関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
被験者募集中第3相
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
被験者募集中第2相
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Children's Hospital of Philadelphia, Philadelphia
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第2/3相
- University of Pennsylvania, Philadelphia
- Jefferson Digestive Health Institute, Philadelphia
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
被験者募集中第3相
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
被験者募集中第3相
- Children's Hospital of Philadelphia (CHOP), Philadelphia
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
被験者募集中第3相
- Children's Hospital of Philadelphia, Philadelphia
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
被験者募集中第4相
- Children's Hospital of Philadelphia, Philadelphia
Precise Infliximab Exposure and Pharmacodynamic Control
被験者募集中第2/3相
- Nemours Children's Health System-Wilmington, Wilmington · 25マイル先
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
被験者募集中
- Children's Hospital of Philadelphia, Philadelphia
他の都市におけるクローン病の試験
- New York City, NY35件の研究
- Boston, MA19件の研究
- Miami, FL19件の研究
- Cleveland, OH19件の研究
- St. Louis, MO19件の研究
- Tyler, TX17件の研究
- Houston, TX17件の研究
- Orlando, FL17件の研究
- Atlanta, GA17件の研究
- San Antonio, TX15件の研究
- San Diego, CA15件の研究
- Los Angeles, CA15件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。